Fundraising Fox

Curt LaBelle

Investor

Managing Partner at Global Health Investment Fund · Venture Partner at Adjuvant Capital

New York

About

Curt LaBelle is a Venture Partner at Adjuvant Capital with over 16 years of experience investing in healthcare companies. He was previously a managing director at Tullis Health Investors and a vice president at Investor Growth Capital. He holds a BS in economics from Brigham Young University and both MD and MBA degrees from Columbia University.

Invests in

BiotechDigital HealthHealthtechMedical Devices

Experience

  1. AXA IM Global Health Private EquityManaging Partnercurrent2022 — present
  2. AXA IM Prime Impact FundAdvisorcurrent2020 — present
  3. Novocuff, Inc.Board Membercurrent2024 — presentUnited States
  4. Vedanta Biosciences, Inc.Board Membercurrent2023 — presentCambridge, Massachusetts, United States
  5. Epion TherapeuticsBoard Membercurrent2022 — presentGreater Boston
  6. Maternal Newborn Health InnovationsBoard Membercurrent2022 — present
  7. Ophirex, Inc.Board Membercurrent2022 — presentSan Francisco Bay Area
  8. Z OpticsChair Of The Board Of Directorscurrent2020 — presentUnited States
  9. Atticus MedicalMember, Board of Directorscurrent2015 — present
  10. Serum InstituteChair, Steering Committee2017 — 2023Pune, India
  11. Atomo Diagnostics (ASX: AT1)Member, Board Of Directors2016 — 2023
  12. Global Health Investment FundManaging Partner2015 — 2023Greater New York City Area
  13. IanTech (acquired by Zeiss)Lead Investor, Head of Global Access Committee2015 — 2023
  14. Revelation Biosciences Inc.Board Member2021 — 2023
  15. Eyenovia (Nasdaq EYEN)Board Member2015 — 2022
  16. Alydia Health (acquired by Organon)Chair, Board Of Directors2018 — 2021
  17. SafeOp Surgical (acquired by Alphatec)Chair Of The Board Of Directors2011 — 2015Stamford, CT
  18. Exagen Inc. (Nasdaq XGN)Chair, Board of Directors2009 — 2015
  19. Tullis Health InvestorsManaging Director2008 — 2015Stamford, CT
  20. Estech (acquired by Atricure)Board Observer2010 — 2013San Francisco Bay Area
  21. Impulse Monitoring (sold to Nuvasive)Chair, Board of Directors, Shareholder Representative2008 — 2011Baltimore, Maryland Area
  22. Sirion TherapeuticsBoard of Directors2006 — 2008
  23. KAI Pharmaceuticals (sold to Amgen)Board of Directors2006 — 2008San Francisco Bay Area
  24. Investor Growth CapitalVice President2005 — 2008Greater New York City Area
  25. Tullis Health InvestorsSenior Associate2002 — 2005Greenwich, CT

Skills & more

Impact Investing1Venture FinancingGrowth CapitalOphthalmology

Languages English · Finnish

From Curt's professional profile.

Investments

Board seats

CoherexEstechExagen DiagnosticsImpulse MonitoringKAI PharmaceuticalsSafeOpSirion TherapeuticsTransMolecular

Per the firm's website.

Frequently asked questions

Who is Curt LaBelle?
Curt LaBelle is a Venture Partner at Adjuvant Capital with over 16 years of experience investing in healthcare companies. He was previously a managing director at Tullis Health Investors and a vice president at Investor Growth Capital. He holds a BS in economics from Brigham Young University and both MD and MBA degrees from Columbia University.
Where does Curt LaBelle work?
Curt LaBelle is Managing Partner at Global Health Investment Fund.
What does Curt LaBelle invest in?
Curt LaBelle invests in Biotech, Digital Health, Healthtech, Medical Devices.
What boards does Curt LaBelle sit on?
Curt LaBelle holds tracked board seats at Coherex, Estech, Exagen Diagnostics, Impulse Monitoring, KAI Pharmaceuticals, SafeOp, Sirion Therapeutics, TransMolecular.
Where did Curt LaBelle go to school?
Curt LaBelle studied at Columbia Business School (MBA); Columbia University Vagelos College of Physicians and Surgeons (MD); Brigham Young University (Bachelor’s Degree, Economics).

Same school

Shared employers